Clinical and drug sensitivity characteristics of invasive non-typhoidal Salmonella enteritis in children aged 0-6 years in Chengdu, China, 2022-2023.
10.7499/j.issn.1008-8830.2408085
- Author:
Ling-Rong YANG
1
;
Chun-Ting ZHOU
;
Jing GUO
1
;
Yu-Lu WU
1
;
Fu XIONG
1
Author Information
1. Department of Pediatric Gastroenterology, Sichuan Provincial Women's and Children's Hospital/Women's and Children's Hospital Affiliated to Chengdu Medical College, Chengdu 610000, China.
- Publication Type:Journal Article
- Keywords:
Child;
Clinical characteristic;
Drug sensitivity;
Enteritis;
Salmonella
- MeSH:
Humans;
Infant;
Child, Preschool;
Enteritis/microbiology*;
Retrospective Studies;
Male;
Salmonella Infections/microbiology*;
Female;
Child;
Salmonella/drug effects*;
Infant, Newborn;
Microbial Sensitivity Tests;
Anti-Bacterial Agents/therapeutic use*
- From:
Chinese Journal of Contemporary Pediatrics
2025;27(3):315-320
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVES:To investigate the clinical characteristics and drug resistance profile of invasive non-typhoidal Salmonella (NTS) enteritis in children in Chengdu, China, providing a reference for rational drug use and empirical treatment in clinical practice.
METHODS:A retrospective analysis was conducted on the clinical data of 130 children with invasive bacterial enteritis due to NTS identified by fecal bacterial culture and the results of drug sensitivity tests for NTS in Chengdu from January 2022 to December 2023.
RESULTS:NTS infections were mainly observed from April to September (113 cases, 86.9%), with a peak in August (36 cases, 27.7%). Children aged <36 months accounted for 86.2% (112/130) of all cases, and the main symptoms were diarrhea (130 cases, 100%), fever (123 cases, 94.6%), and hematochezia (112 cases, 86.2%). The 130 NTS isolates exhibited a sensitivity rate of 64.6% to ceftriaxone and 63.8% to cefotaxime, and a sensitivity rate of >90.0% to piperacillin-tazobactam and nitrofurantoin (nitrofurans). The detection rate of multidrug-resistant strains was 48.5% (63/130), and the clinical efficacy of third-generation cephalosporins used in 38 patients (29.2%) was inconsistent with the results of drug sensitivity tests.
CONCLUSIONS:The peak of invasive NTS enteritis in children aged 0-6 years occurs in August in the Chengdu area, with a relatively high incidence rate in children aged <36 months. The situation of drug resistance is severe for NTS, and piperacillin-tazobactam may be an effective option for treating multidrug-resistant NTS infections in children, while nitrofuran antibiotics might be used to treat such infections.
